Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-15
DOI
10.1038/ncomms7776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- c-Met Targeting Enhances the Effect of Irradiation and Chemical Agents against Malignant Colon Cells Harboring a KRAS Mutation
- (2014) Yingbo Li et al. PLoS One
- Modulation of c-Met signaling and cellular sensitivity to radiation
- (2013) Vikas Bhardwaj et al. CANCER
- Macrophages promote epithelial repair through hepatocyte growth factor secretion
- (2013) F. D'Angelo et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
- (2013) Shinya Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Matriptase-Prostasin Reciprocal Zymogen Activation Complex with Unique Features
- (2013) Stine Friis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Matriptase Proteolytically Activates Influenza Virus and Promotes Multicycle Replication in the Human Airway Epithelium
- (2013) A. Beaulieu et al. JOURNAL OF VIROLOGY
- Design and Synthesis of Potent, Selective Inhibitors of Matriptase
- (2012) Éloïc Colombo et al. ACS Medicinal Chemistry Letters
- Matriptase Protects Against Experimental Colitis and Promotes Intestinal Barrier Recovery
- (2011) Sarah Netzel-Arnett et al. INFLAMMATORY BOWEL DISEASES
- Strong expression association between matriptase and its substrate prostasin in breast cancer
- (2011) Christopher Bergum et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Breast Cancer-Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown
- (2011) S. Previdi et al. MOLECULAR CANCER THERAPEUTICS
- Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
- (2010) Ian M. Buchanan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Loss of Matriptase Suppression Underlies Spint1 Mutation-Associated Ichthyosis and Postnatal Lethality
- (2009) Roman Szabo et al. AMERICAN JOURNAL OF PATHOLOGY
- Epithelial Integrity Is Maintained by a Matriptase-Dependent Proteolytic Pathway
- (2009) Karin List et al. AMERICAN JOURNAL OF PATHOLOGY
- Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA
- (2009) Kate A. Owen et al. BIOCHEMICAL JOURNAL
- Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice
- (2009) R. Szabo et al. DEVELOPMENT
- Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity
- (2008) Roman Szabo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started